QLIFE Stock Overview
Qlife Holding AB (publ), a med-tech company, manufactures and sells in-vitro diagnostic analyzers and reagents.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
Qlife Holding AB (publ) Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | kr0.003 |
| 52 Week High | kr0.50 |
| 52 Week Low | kr0.0027 |
| Beta | 0.49 |
| 1 Month Change | -72.22% |
| 3 Month Change | -83.96% |
| 1 Year Change | -98.72% |
| 3 Year Change | -99.99% |
| 5 Year Change | n/a |
| Change since IPO | -99.97% |
Recent News & Updates
Shareholder Returns
| QLIFE | SE Medical Equipment | SE Market | |
|---|---|---|---|
| 7D | 0% | 2.7% | 1.1% |
| 1Y | -98.7% | -6.9% | 10.2% |
Return vs Industry: QLIFE underperformed the Swedish Medical Equipment industry which returned -6% over the past year.
Return vs Market: QLIFE underperformed the Swedish Market which returned 11.1% over the past year.
Price Volatility
| QLIFE volatility | |
|---|---|
| QLIFE Average Weekly Movement | 29.1% |
| Medical Equipment Industry Average Movement | 7.6% |
| Market Average Movement | 6.3% |
| 10% most volatile stocks in SE Market | 13.3% |
| 10% least volatile stocks in SE Market | 3.6% |
Stable Share Price: QLIFE's share price has been volatile over the past 3 months.
Volatility Over Time: QLIFE's weekly volatility (29%) has been stable over the past year, but is still higher than 75% of Swedish stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2019 | 13 | Thomas Warthoe | www.qlifeholding.com |
Qlife Holding AB (publ), a med-tech company, manufactures and sells in-vitro diagnostic analyzers and reagents. The company offers Egoo Health Platform, an integrated platform with a measuring instrument with disposable capsules and software, where each capsule contains a test for a specific biomarker or virus.
Qlife Holding AB (publ) Fundamentals Summary
| QLIFE fundamental statistics | |
|---|---|
| Market cap | kr1.94m |
| Earnings (TTM) | -kr159.96m |
| Revenue (TTM) | kr244.00k |
7.9x
P/S Ratio0.0x
P/E RatioIs QLIFE overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| QLIFE income statement (TTM) | |
|---|---|
| Revenue | kr244.00k |
| Cost of Revenue | kr6.56m |
| Gross Profit | -kr6.31m |
| Other Expenses | kr153.64m |
| Earnings | -kr159.96m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.25 |
| Gross Margin | -2,586.89% |
| Net Profit Margin | -65,555.74% |
| Debt/Equity Ratio | -60.8% |
How did QLIFE perform over the long term?
See historical performance and comparison